Related references
Note: Only part of the references are listed.Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials
Fan Tang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
The inhibitory effect of CTAB on human osteosarcoma through the PI3K/AKT signaling pathway
Wacili Da et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2021)
Characteristics and prognosis of telangiectatic osteosarcoma: a population-based study using the Surveillance, Epidemiology and End Results (SEER) database
Mingfang Xu et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Novel therapeutic strategies for spinal osteosarcomas
M. Akhtar Anwar et al.
SEMINARS IN CANCER BIOLOGY (2020)
lncRNA FLVCR-AS1 promotes osteosarcoma growth by targeting miR381-3p/CCND1
Guang Yang et al.
ONCOTARGETS AND THERAPY (2020)
Gemcitabine and Rapamycin Exhibit Additive Effect against Osteosarcoma by Targeting Autophagy and Apoptosis
Takashi Ando et al.
CANCERS (2020)
Diagnostic challenges and surgical management of co-existent osteoblastoma and aneurysmal bone cyst of the lumbar spine in a child: case report Kaunda
Kaunda Ibebuikei et al.
AFRICAN HEALTH SCIENCES (2019)
Current and future therapeutic approaches for osteosarcoma
Douglas J. Harrison et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Telangiectatic osteosarcoma: Outcome analyses and a diagnostic model for differentiation from aneurysmal bone cyst
Jun-qiang Yin et al.
JOURNAL OF BONE ONCOLOGY (2018)
Effect of Temporal Changes in Therapeutic Exposure on Self-reported Health Status in Childhood Cancer Survivors
Kirsten K. Ness et al.
ANNALS OF INTERNAL MEDICINE (2017)
Orthopedic Surgery Options for the Treatment of Primary Osteosarcoma
German A. Marulanda et al.
Cancer Control (2017)
Transition from Tumor Tissue to Bone Marrow in Patients with Appendicular Osteosarcoma after Neoadjuvant Chemotherapy
Zhi-Ping Deng et al.
CHINESE MEDICAL JOURNAL (2017)
Telangiectatic osteosarcoma: a review of 87 cases
Andrea Angelini et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
Pratistha Koirala et al.
SCIENTIFIC REPORTS (2016)
How to explain the role of magnetic resonance imaging on evaluating tumour response of osteosarcoma to neoadjuvant chemotherapy?
Hui Li et al.
INTERNATIONAL ORTHOPAEDICS (2015)
Preoperative easily misdiagnosed telangiectatic osteosarcoma: clinical-radiologic-pathologic correlations
Zhen-Hua Gao et al.
CANCER IMAGING (2013)
Telangiectatic osteosarcoma: a review of literature
Jun-jian Liu et al.
ONCOTARGETS AND THERAPY (2013)
Telangiectatic Osteosarcoma
Nikhil A. Sangle et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2012)
Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma
Nicholas M. Bernthal et al.
CANCER (2012)
Targeting the osteosarcoma cancer stem cell
Valerie A. Siclari et al.
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2010)
A Case of an Aneurysmal Bone Cyst of a Metatarsal: Review of the Differential Diagnosis and Treatment Options
Serkan Iltar et al.
JOURNAL OF FOOT & ANKLE SURGERY (2009)
Survival trends in osteosarcoma of humerus
R. Shenoy et al.
EUROPEAN JOURNAL OF CANCER CARE (2008)
Telangiectatic osteosarcoma of the spine: a case report
R. Amritanand et al.
EUROPEAN SPINE JOURNAL (2008)
Telangiectatic osteosarcoma: The St. Jude Children's Research Hospital's experience
Aaron Weiss et al.
CANCER (2007)
Pathology of primary malignant bone and cartilage tumours
L. B. Rozeman et al.
INTERNATIONAL ORTHOPAEDICS (2006)
Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution
G Bacci et al.
EUROPEAN JOURNAL OF CANCER (2005)
Share Paper
